Sii HibPRO™ is a Hib Conjugate Vaccine containing capsular polysaccharide of H. influenzae Type b strain, coupled to Tetanus toxoid. Sii HibPRO is indicated for active immunization against Haemophilus Influenzae Type b infection for all children from the age of 6 weeks to 5 years. Sii HibPRO does not protect against disease due to other types of H. influenzae nor against meningitis caused by other organisms.
For infants 6 weeks to 6 months of age, the immunizing dose is three separate injections of 0.5 ml given at approximately 4 weeks interval. All vaccinated children should receive a single booster dose at 12-18 months of age, but not less than 2 months after the previous dose.
In previously unvaccinated infants, the number of doses of Haemophilus b Conjugate Vaccine needed depends on the age at which the immunization series is begun.
- 7 through 11 months of age should receive two separate injections approximately 2 months apart
- 12 through 14 months of age should receive one injection
- 15 to 60 months of age receive a single injection
Preterm infants should be vaccinated according to their chronological age, from birth .
Sii HibPRO can be used as Pentavalent (DTP-HB-Hib) vaccine by reconstituting with Sii Q-VAC (DTP-HB vaccine) for simultaneous administration via single injection. Sii HibPRO can be used as Quadrivalent (DTP-Hib) vaccine by reconstituting with Sii Triple Antigen (DTP Vaccine) for simultaneous administration via single injection.
For latest IAP updates see revised immunization schedule.
Haemophilus influenzae type b
Serum Institute of India Ltd.
Known hypersensitivity to any component of the vaccine or a severe reaction to a previous dose. The vaccine will not harm individuals previously infected with the Hib bacteria. Children infected with Human Immunodeficiency Virus (HIV) both asymptomatic and symptomatic, should be immunized with Hib vaccine according to standard schedules. All vaccines can be administered to children with minor illness such as diarrhoea or other low grade febrile illness; children with moderate or severe febrile illness should be vaccinated as soon as they have recovered from the acute phase of the illness.